Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.35 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.35 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.35 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27714482 | 0.98 | SMN1; SMN2 (0.42) | SMN1; SMN2KDM4EEPHX1EPHX2RECQL | |
| SCHEMBL5317403 | 0.91 | KDM4E (0.39) | SMN1; SMN2KDM4EEPHX1EPHX2RECQL | |
| SCHEMBL26706476 | 0.88 | ACHE (0.41) | SMN1; SMN2KDM4EEPHX1EPHX2RECQL | |
| SCHEMBL13832821 | 0.86 | — | — | |
| SCHEMBL15079109 | 0.86 | — | — | |
| SCHEMBL2549878 | 0.86 | — | — | |
| Hydrochloric Acid SCHEMBL13739081 | 0.84 | HRH3 (0.40) | SMN1; SMN2KDM4EEPHX1EPHX2RECQL | |
| Hydrochloric Acid SCHEMBL13738417 | 0.84 | HRH3 (0.40) | SMN1; SMN2KDM4EEPHX1EPHX2RECQL | |
| Hydrochloric Acid SCHEMBL13738414 | 0.84 | HRH3 (0.40) | SMN1; SMN2KDM4EEPHX1EPHX2RECQL | |
| SCHEMBL20960378 | 0.81 | SMN1; SMN2 (0.41) | SMN1; SMN2KDM4EEPHX1EPHX2RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119528174-A | Modified MWW molecular sieve and preparation method thereof, xylene isomerization catalyst and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-02-28 | — | — | CN | claimed |
| US-7790885-B2 | Process for preparing phenoxypyridine derivatives | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2010-09-07 | — | — | US | claimed |
| CN-101454286-A | Process for producing phenoxypyridine derivative | EISAI R&D MAN CO LTD (JP) | 2009-06-10 | — | — | CN | claimed |
| EP-2058302-A1 | METHOD FOR PRODUCING PHENOXYPYRIDINE DERIVATIVE | Eisai R&D Management Co., Ltd. (JP) | 2009-05-13 | — | — | EP | claimed |
| US-20080214815-A1 | Process for preparing phenoxypyridine derivatives | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2008-09-04 | — | — | US | claimed |
| WO-2007069053-A1 | BENZIMIDAZOLE ANTAGONISTS OF THE H-3 RECEPTOR | PFIZER PRODUCTS INC. (US) | 2007-06-21 | — | — | WO | claimed |
| CN-119528174-A | Modified MWW molecular sieve and preparation method thereof, xylene isomerization catalyst and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-20250034127-A1 | AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR DISEASES OF THE CNS | UNIVERSITÉ PARIS CITÉ (FR) | 2025-01-30 | — | — | US | disclosed |
| EP-4433162-A1 | AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR DISEASES OF THE CNS | Samsara Therapeutics Inc. (US) | 2024-09-25 | — | — | EP | disclosed |
| CN-118647613-A | Autophagy inducing compounds and uses thereof, in particular for central nervous system diseases | 轮回治疗公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-118308790-A | Adjustable double A-site hybrid ferroelectric perovskite single crystal photovoltaic device and preparation method and application thereof | 暨南大学 | 2024-07-09 | — | — | CN | disclosed |
| WO-2024020084-A1 | HETEROARYL COMPOUNDS AS LIGAND DIRECTED DEGRADERS OF IRAK4 | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-01-25 | — | — | WO | disclosed |
| EP-3640248-B1 | AMINOPYRIMIDINE DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF | BEIJING ADAMADLE BIOTECHNOLOGY LLC (CN) | 2023-08-23 | — | — | EP | disclosed |
| CN-1665807-A | Novel physiolgically active substances | MERCIAN CORP (JP) | 2005-09-07 | — | — | CN | disclosed |
| EP-1548121-A1 | NOVEL PHYSIOLOGICALLY ACTIVE SUBSTANCES | MERCIAN CORPORATION (JP) | 2005-06-29 | — | — | EP | disclosed |
| EP-1541570-A1 | NOVEL PHYSIOLOGICALLY ACTIVE SUBSTANCE | MERCIAN CORPORATION (JP) | 2005-06-15 | — | — | EP | disclosed |
| EP-1508570-A1 | NOVEL PHYSIOLGICALLY ACTIVE SUBSTANCES | MERCIAN CORPORATION (JP) | 2005-02-23 | — | — | EP | disclosed |
| CN-1143848-C | 2-arylethyl- (piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists | - | 2004-03-31 | — | — | CN | disclosed |
| WO-2003044014-A1 | INDOLE-2-CARBOXAMIDES AS FACTOR XA INHIBITORS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-05-30 | — | — | WO | disclosed |
| CN-1295563-A | 2-arylethyl- (piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists | HOFFMANN LA ROCHE (CH) | 2001-05-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250034127-A1 | AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR DISEASES OF THE CNS | SQSTM1, TFEB, BECN1 | SMN1; SMN2 706/4885KDM4E 2987/4885EPHX1 2268/4885 |
| US-20080214815-A1 | Process for preparing phenoxypyridine derivatives | FIP1L1, SKP1, TET2 | SMN1; SMN2 2408/4885KDM4E 331/4885EPHX1 3360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.